...
首页> 外文期刊>Journal of Clinical Oncology >Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease.
【24h】

Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease.

机译:甲状腺疾病患者外周血中甲状腺球蛋白,甲状腺过氧化物酶和RET / PTC1 mRNA转录物的检测。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Detection of mRNA transcripts for thyroglobulin (TG), thyroid peroxidase (TPO) and RET/PTC1 in the peripheral blood of patients with thyroid disease. PATIENTS AND METHODS: TG, TPO, and RET/PTC1 mRNA were analyzed in 52 peripheral-blood samples from 44 patients diagnosed with thyroid carcinoma (24 patients), adenoma (five patients), and nodular hyperplasia (15 patients) by reverse transcription-polymerase chain reaction (RT-PCR). RESULTS: TG and TPO were identified in 13 patients (54.2%) with thyroid carcinoma, which includes five of eight patients with no clinical evidence of disease at the time of blood collection. Four of 5 patients had cervical lymph node metastases and/or extrathyroid extension at the time of the initial surgery. RET/PTC1 mRNA was detected in the peripheral blood of only one patient with papillary thyroid carcinoma. This sample was also positive for TG and TPO. TG and TPO were detected in two patients (10%) with benign thyroid nodules. All positive samples from patients with benign thyroid lesions were collected before surgery, whereas all samples collected after surgery were negative. RET/PTC1 mRNA was not detected in any of the patients with benign thyroid nodules. RT-PCR positivity for TG and TPO mRNA was higher in patients with carcinoma than in patients with benign lesions (P = .002). CONCLUSION: TG, TPO, and RET/PTC1 mRNA are detectable in the peripheral blood of patients with thyroid disease, which correlates with a diagnosis of carcinoma.
机译:目的:检测甲状腺疾病患者外周血中甲状腺球蛋白(TG),甲状腺过氧化物酶(TPO)和RET / PTC1的mRNA转录本。病人与方法:通过逆转录分析法对44例经诊断患有甲状腺癌(24例),腺瘤(5例)和结节性增生(15例)的患者的52例外周血样本中的TG,TPO和RET / PTC1 mRNA进行了分析。聚合酶链反应(RT-PCR)。结果:在13例甲状腺癌患者中检出了TG和TPO(54.2%),其中8例患者中有5例在采血时没有临床证据。 5例患者中有4例在初次手术时出现了颈部淋巴结转移和/或甲状腺外延伸。仅一名甲状腺乳头状癌患者的外周血中检测到RET / PTC1 mRNA。该样品的TG和TPO也呈阳性。在两名甲状腺良性结节患者(10%)中检测到TG和TPO。甲状腺良性病变患者的所有阳性样品在手术前收集,而手术后收集的所有样品均为阴性。在任何甲状腺良性结节患者中均未检测到RET / PTC1 mRNA。癌患者中TG和TPO mRNA的RT-PCR阳性率高于良性病变患者(P = .002)。结论:甲状腺疾病患者外周血中可检测到TG,TPO和RET / PTC1 mRNA,这与癌症的诊断有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号